Arlington Trust CO LLC Neogenomics Inc Transaction History
Arlington Trust CO LLC
- $453 Million
- Q3 2024
A detailed history of Arlington Trust CO LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Arlington Trust CO LLC holds 108 shares of NEO stock, worth $1,708. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108
Previous 108
-0.0%
Holding current value
$1,708
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
276Shares Held
127MCall Options Held
581KPut Options Held
115K-
Black Rock Inc. New York, NY19.7MShares$311 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$223 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$139 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$106 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$105 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.99B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...